From: PKCδ regulates the vascular biology in diabetic atherosclerosis
PKC isoforms | Working model | Pathophysiological processes |
---|---|---|
PKCα | PAECs | Increases endothelial permeability [133] |
PKCα | A7r5 rat aortic VSMCs, human umbilical artery VSMCs, human aortic VSMCs | Inhibits serum withdrawal-induced VSMCs apoptosis [83] |
PKCα | RAW 264.7, THP-1 | Increases monocytes/macrophages-mediated inflammation [88, 97, 134] |
PKCβ | Diabetic patients, capillary BRECs, BRPs | Increases vasoconstriction [30] Inhibits vasodilation [135] |
PKCβ | BAECs, HAECs, HUVECs | Increases endothelial VCAM-1 and ICAM-1 expression, enhances plaque formation, complexity, and cholesterol content [137] |
PKCβ | Human VSMCs | Mediates thrombin-stimulated VSMCs migration [72] |
PKCβ | A7r5 rat aortic VSMCs, human umbilical artery VSMCs, human aortic VSMCs | Inhibits serum withdrawal-induced VSMCs apoptosis [83] |
PKCβ | THP-1 cells, Raw 264.7, U937, diabetic ApoE-null mice | Increases monocytes/macrophages-mediated inflammation [134, 136, 137, 139] |
PKCβ | Diabetic rats | Increases macrophages recruitment and ICAM-1 and MCP-1 protein expression in the kidney [138] |
PKCδ | Capillary BRECs, BRPs, HUVECs, diabetic rats | Increases vasoconstriction [14, 29, 30] Inhibits vasodilation [13] |
PKCδ | HRMECs, diabetic mice | Increases endothelial permeability [19] |
PKCδ | HAECs, ECV 304, aortic segments from old mice | Mediates NADPH oxidase-dependent oxidant stress [42] |
PKCδ | HUVECs | Increases endothelial apoptosis |
PKCδ | Rat aortic VSMCs, human VSMCs | Promotes VSMCs migration and proliferation |
PKCδ | Human VSMCs | Mediates thrombin-stimulated VSMCs migration [72] |
PKCδ | RAW 264.7, THP-1, diabetic rats | Increases monocytes/macrophages-mediated inflammation [86, 88, 97] |
PKCδ | Diabetic ApoE-null mice | Increases macrophages apoptosis and decreases their proliferation, alleviates plaque progression and splenomegaly [85] |
PKCδ | Tsc1- null MEFs | Increases LDLR expression [115] |